Featured molecule
Founded in 2006, q.e.d. life sciences aims to combine into a cutting- edge technology platform systems level target identification with molecular-level directed evolution and advanced drug target crystal-lography as basis for structure guided drug discovery methods. Combination of genetic methods which structure based lead discovery enables us to rapidly translate initial leads into robust and resistance-resistant therapeutic drug candidates. Licensed products include proprietary protein drug target crystallography automation technologies.
President and
Founder
Dr. Bernhard Rupp, Drug Target Crystallography and Drug
Discovery
Board of Directors
Advisory Board
EvoTheRx Evolutionary Therapeutics
Advanced Drug Target Crystallography Automation
q.e.d. life science discoveries, inc., is a closely held California stock corporation
|
|